Sabrina Martucci-Johnson

Sabrina Martucci Johnson is a life sciences executive committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven to transform the status of healthcare for women by identifying, developing and bringing to market a diverse portfolio of novel therapies that expand treatment options and improve outcomes for women. Sabrina has a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change. Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB).
Sabrina has an MIM with honors from Thunderbird; a MSc. in Biochemical Engineering from University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.
Sabrina currently serves on the boards of ATAI Life Sciences, Biocom California, as board chair-elect, and the Clearity Foundation as former board chair.
In 2023 Ms. Johnson was recognized as one of Fierce Pharma’s Most Influential People in Biopharma for her contributions to innovation and advocacy in the women’s health space.